Two River is a merchant bank focused on the life science sector.
We work with experienced teams to build outstanding companies that improve health outcomes and quality of life. At Two River we tailor our approach to the needs of each opportunity, partnering with management to create, finance or operate development-stage companies in the life sciences and healthcare sectors.Two River invests in companies with strong intellectual property and proven leadership teams who have demonstrated prior success developing innovative technologies in the life sciences sector.Two River is uniquely positioned to understand and balance the needs of the finance and life science communities. Our experience building companies spans a range of industry sectors including oncology, cardiovascular disease, ophthalmology, neurological disorders and animal health. We consider each of our investments to be a partnership, often working closely with portfolio companies on product development, regulatory and corporate strategy as well as day-to-day business operations.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jul 26, 2021
ByHeart
|
Series B | $90M | Health Care | — |
Sep 14, 2020
Neogene Therapeutics
|
Series A | $110M | Biotechnology | — |
Apr 15, 2020
ByHeart
|
Series A | $70M | Health Care | — |
May 15, 2013
Kite Pharma
|
Series A | $20M | Biotechnology | — |
Mar 9, 2011
Kite Pharma
|
Series A | $15M | Biotechnology | — |